Our Faculty
Smita Das, M.D., Ph.D., M.P.H.
Stanford Medicine
Biography
Smita Das, M.D., Ph.D., MPH is Board Certified in Psychiatry, Addiction Psychiatry, and Addiction Medicine and has over 20 years of research experience in health care quality and addiction. She is a past president of an APA District Branch, is chair of the Council on Addictions at the APA, is a member of the Foundations Workplace Mental Health advisory council. In addition to her work at Lyra as VP of Psychiatry and Complex Care, Dr. Das practices in addictions at Stanford School of Medicine where she is a Clinical Associate Professor.
Publications of Smita Das, M.D., Ph.D., M.P.H.
Pharmacologic Management of Opioid Use Disorder – Interview
0.50 CMEs
A discussion on medications for opioid use disorder, highlighting initiation timing differences between methadone, buprenorphine, and naltrexone. Key topics include preventing precipitated withdrawal, addressing early medication depletion, and maintaining treatment despite positive tests for other substances.
Smita Das, M.D., Ph.D., M.P.H.
Stanford Medicine
32.32 minutes of audio interview
Pharmacologic Management of Opioid Use Disorder
1.00 CMEs
In this video lecture, Dr. Das provides an in-depth exploration of opioid use disorder (OUD) and its management. The lecture begins with an overview of substance use and opioid misuse, followed by a detailed examination of opioid intoxication and withdrawal. It then offers a comprehensive guide to OUD treatment, emphasizing the importance of tailored patient assessment for effective treatment outcomes. Dr. Das also discusses the use of methadone and buprenorphine for managing OUD, as well as the efficacy of extended-release naltrexone. The role of naloxone in managing OUD is highlighted, along with a clinical case illustrating the initiation of buprenorphine treatment.
Smita Das, M.D., Ph.D., M.P.H.
Stanford Medicine
54.01 minutes in 10 sections
